Research alert
This entire item is of approximately 150 words
  • Click here to read this item in full online now
  • Click here to subscribe to Biomedical Materials and immediately access all its archives
  • Click here to review the contents of the March 2006 issue of Biomedical Materials and download it online

  • Issue: March 2006, page: 10

    CardioTech seeks investigational exemption for bypass graft

    CardioTech International Inc is starting the process to gain an Investigational Device Exemption (IDE) from the US Food and Drug Administration (FDA) for its patented artificial coronary artery bypass graft, trademarked CardioPass.

    Read related items on:

          
  • Medical
  • CardioPass
  • CardioTech International
  • US Food and Drug Administration

  • International Newsletters ©
     
                                                 Advertising on this site | Privacy Policy | Contact